Nevertheless, our results may, at least partly, contribute to better understanding, the role of VEGF/VEGFR-1 signalling in the complex breast cancer development and may contribute to reassessing therapeutic approaches to this severe disease. This evidence concerns the gene FLT1 and breast carcinoma.